Bryan Tordon

Bryan Tordon

Auto-generated profile, based on publicly available information

Bryan Tordon

Department of Laboratory Medicine and Pathology University of Calgary Calgary Alberta Canada

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2023 in Vox Sanguinis
Verified
Journal Article
Closed access
BTBryan Tordon
Bryan Tordon
CMCelina Montemayor
Celina Montemayor
GCGwen Clarke
Gwen Clarke
SOSheila O'Brien
Sheila O'Brien
MGMindy Goldman
Mindy Goldman

16 September 2023 in Transfusion
Verified
Journal Article
Closed access
BTBryan Tordon
Bryan Tordon
SDSteven Jeffrey Drews
Steven Jeffrey Drews
FFFrancine Flahr
Francine Flahr
KBKathleen Bennett
Kathleen Bennett
TGTeresa Gaziano
Teresa Gaziano
MSMatthew Seftel
Matthew Seftel

1 October 2024 in Transfusion
Verified
Journal Article
Open access
BTBryan Tordon
Bryan Tordon
HMHarley Meirovich
Harley Meirovich
AMAmie Malkin
Amie Malkin
KPKaterina Pavenski
Katerina Pavenski
AMAmy Moorehead
Amy Moorehead
YLYulia Lin
Yulia Lin
Background: It is uncertain how transfusion knowledge translates to practice. The purpose of the study was to determine if higher scores on a validated Transfusion Camp knowledge assessment test were associated with transfusion order appropriateness.Study Design and Methods: Eligible participants included postgraduate trainees and faculty physicians who had prescribed at least four transfusion orders in the preceding 6 months at two hospitals. Participant data and knowledge were collected using a web‐based questionnaire with a validated Transfusion Camp knowledge assessment tool. The most recent 4–10 consecutive transfusion orders per prescriber were independently dually adjudicated for appropriateness based on published criteria. The primary outcome was the correlation between the score on six questions on red blood cells (RBCs), platelets (PLTs), and plasma from the validated test and the percentage order appropriateness. Generalized linear regression was conducted to determine if factors (sex, specialty, participation in Transfusion Camp, previous transfusion education, self‐rated knowledge) were associated with appropriate orders.Results: Seventy‐four participants (45 trainees, 29 faculty; 31 females, 43 males) completed the test. Median score was 66.7% (interquartile range [IQR]: 50.0, 83.3) for six questions on RBCs, PLTs, and plasma transfusions. Of 546 transfusion orders adjudicated, appropriateness was 90.7% (95% confidence interval [CI]: 87.9%–93.0%). The correlation between prescriber test scores and order appropriateness was very weak (r = −.08). In multivariable analysis, female prescribers (p = .02) and beginner (vs. intermediate) self‐rated knowledge (p = .01) were associated with higher transfusion appropriateness.Conclusion: Transfusion knowledge test scores did not correlate with order appropriateness. Factors other than knowledge are key to understanding how to improve appropriate blood use.

11 February 2026 in Vox Sanguinis
Verified
Journal Article
Open access
BTBryan Tordon
Bryan Tordon
GCGwen Clarke
Gwen Clarke
JWJacqueline Wong
Jacqueline Wong
APAnn Peregrin
Ann Peregrin
AGAkash Gupta
Akash Gupta
Background and Objectives: Foetal and neonatal alloimmune thrombocytopaenia (FNAIT) is a potentially severe immune‐mediated condition that is believed to be under‐identified in the Canadian population. The Canadian Blood Services National Platelet Immunology Reference Laboratory (NPIRL) serves as a centralized referral laboratory for FNAIT investigations across Canada. Diagnostic evaluation includes human platelet antigen (HPA) genotyping and maternal anti‐HPA antibody testing. This study is a review of all FNAIT investigations referred to NPIRL to assess testing patterns, antibody detection rates and evidence of under identification at a national level. Materials and Methods: All maternal, paternal and neonatal samples related to FNAIT investigations between 20 January 2014 and 31 December 2024 were extracted from the NPIRL database. The geographic origin of samples, HPA genotyping and antibody specificity, if present, were documented. Results: A total of 1986 samples (1076 maternal, 620 paternal and 290 neonatal) were received for FNAIT investigation over the 11‐year study period. One‐hundred and thirty‐five HPA antibodies were identified in 130 of the maternal samples tested, with anti‐HPA‐1a and HPA‐5b being the most frequently detected specificities. Despite a modest increase in annual referrals, the total number of investigations and antibody‐positive cases was substantially lower than expected based on Canadian birth rates and published FNAIT incidence estimates. Conclusion: Referral patterns and laboratory findings from NPIRL demonstrate a marked discrepancy between expected FNAIT incidence and observed diagnostic activity in Canada, indicating that FNAIT is substantially under‐identified. These findings highlight the need for improved recognition, standardized investigation pathways and enhanced diagnostic strategies to reduce missed cases and improve neonatal outcomes.